Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine

European Journal of Pharmacology

Volumn 322, Issue 2-3, 1997, Pages 211-220

  Kurz, Michael A ^a   Bullough, David A ^a   Buggé, Christopher J L ^b   Mullane, Kevin M ^a   Young, Mark A ^a  

^a Gensia Inc   (United States)

^b CEDRA Corporation   (United States)

Author keywords

Adenosine; Coronary vessel; Myocardial ischemia; Myocardial stunning; Reperfusion injury

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; GP 531; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; FEMALE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; STUNNED HEART MUSCLE; SWINE;

ADENOSINE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CARDIOTONIC AGENTS; DEOXYRIBONUCLEOSIDES; FEMALE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; SWINE; SWINE, MINIATURE;

EID: 0030957588     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00011-3     Document Type: Article

References (53)

1. Abd-Elfattah, A.S., M. Ding, C.M. Dyke and A.S. Wechsler, 1993, Protection of stunned myocardium. Selective nucleoside transport blocker administered after 20 minutes of ischemia augments recovery of ventricular function, Circulation 88, 336.
2. ATP channels, and ischemic preconditioning in dogs, Am. J. Physiol. 264, H1327.
3. Balcells, E., J. Suarez and R. Rubio, 1992, Functional role of intravascular adenosine receptors, Eur. J. Pharmacol. 210, 1.
4. Borst, M.M. and J. Schrader, 1991, Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine, Circ. Res. 68, 797.
5. Bullough, D.A., C. Zhang, A. Montag, K.M. Mullane and M.A. Young, 1994, Adenosine-mediated inhibation of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vitro, J. Clin. Invest. 94, 1524.
6. Bullough, D.A., M.J. Magill and K.M. Mullane, 1995, Compartmentation of cardiac adenosine: importance of intravascular adenosine for cardioprotection, Circulation 92, 1-523.
7. Cronstein, B.N., S.B. Kramer, G. Weissman and R. Hirschhorn, 1983, Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils, J. Exp. Med. 158, 1160.
8. Cronstein, B.N., R.I. Levin, J. Belanoff, G. Weissman and R. Hirschhorn, 1986, Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells, J. Clin. Invest. 78, 760.
9. 2 generation, respectively, J. Clin. Invest. 85, 1150.
10. 31P nuclear magnetic resonance, J. Cardiovasc. Pharmacol. 5, 1040.
11. Dorheim, T.A., A. Hoffman, D.G.L. Van Wylen and R.M. Mentzer, 1991, Enhanced interstitial adenosine attenuates myocardial stunning, Surgery 110, 136.
12. Engler, R.L. and H.E. Gruber, 1992, Adenosine: an autocoid, in: The heart and Cardiovascular System, 2nd edn., ed. H.A. Fozzard (Raven Press, New York, NY) p. 1745.
13. Engler, R.L., G.W. Schmid-Schoenbein and R.S. Pavelec, 1983, Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog, Am. J. Pathol. 111, 98.
14. Feldman, M.D., C.R. Ayers, M.R. Lehman, H.E. Taylor, V.L. Gordon, P.J. Sabia, D. Ras, T.C. Skalak and J. Linden, 1992, Improved detection of ischemia-induced increases in coronary sinus adenosine in patients with coronary artery disease, Clin. Chem. 38, 256.
15. Galiñanes, M., D. Bullough, K.M. Mullane and D.J. Hearse, 1992a, Sustained protection by acadesine against ischemia- and reperfusion-induced injury, Circulation 86, 5589.
16. Galiñanes, M., K.M. Mullane, D. Bullough and D.J. Hearse, 1992b, Acadesine and myocardial protection: studies of time of administration and dose-response relationships in the rat, Circulation 86, 598.
17. Galiñanes, M., Y. Qiu, H. Van Belle and D.J. Hearse, 1993, Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused rabbit heart, Cardiovasc. Res. 27, 90.
18. Gruber, H.E., M.E. Hoffer, D.R. McAllister, P.K. Laikind, T.A. Lane, G.W. Schmid-Schoenbein and R.L. Engler, 1989, Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes and injury, Circulation 80, 1400.
19. Gruver, E.J., D. Toupin, T.W. Smith and J.D. Marsh, 1994, Acadesine improves tolerance to ischemic injury in rat cardiac myocytes, J. Mol. Cell. Cardiol. 26, 1187.
20. Headrick, J.P., G.P. Patherne and R.M. Berne, 1992, Myocardial adenosine formation during hypoxia: effects of ecto-5′-nucleotidase inhibition, J. Mol. Cell. Cardiol. 24, 295.
21. Hori, M., M. Kitakaze, S. Takashima, T. Morioka, H. Sato, T. Minamino, K. Node, K. Komamura, M. Inoue and T. Kamada, 1994, AICA riboside improves myocardial ischemia in coronary microembolization in dogs, Am. J. Physiol. 267, H1483.
22. Hoshida, S., T. Kuzuya, M. Nishida, N. Yamashita, H. Oe, M. Hori, T. Kamada and M. Tada, 1994, Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts, Cardiovasc. Res. 28, 1083.
23. Itoya, M., T. Miura, J. Sakamoto, K. Urabe and O. Iimura, 1994, Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning, J. Cardiovasc. Pharmacol. 24, 846.
24. Kirkebøen, K.A., A. Ilebekk, T. Tønnessen, E. Leistad, P.A. Naess, G. Christensen and G. Aksnes, 1994, Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition, Am. J. Physiol. 267, H57.
25. Kitakaze, M., M. Hori, S. Takashima, H. Sato, M. Inoue and T. Kamada, 1993, Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage, Circulation 87, 208.
26. Kitakaze, M., M. Hori, T. Morioka, T. Minamino, S. Takashima, H. Sato, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue and T. Kamada, 1994, The infarct size limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release, Circulation 89, 1237.
27. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart, Cardiovasc. Res. 28, 1057.
28. 1 adenosine receptors in rabbit heart, Circulation 84, 350.
29. Mullane, K.M. and D. Bullough, 1995, Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine, J. Mol. Cell. Cardiol. 27, 1041.
30. Mullane, K. and M. Young, 1993, Acadesine: prototype adenosine regulating agent for treating myocardial ischemia-reperfusion injury, Drug Dev. Res. 28, 336.
31. Mullane, K.M., N. Read, J.A. Salmon and S. Moncada, 1983, Role of leukocytes in acute myocardial infarction in anesthetized dogs, relationship to myocardial salvage by anti-inflammatory drugs, J. Pharmacol. Exp. Ther. 228, 510.
32. Nees, S., V. Herzog, B.F. Becker, M. Bock, C. Des Rosiers and E. Gerlach, 1985, The coronary endothelium: a highly active metabolic barrier for adenosine, Basic Res. Cardiol. 80, 1515.
33. Norton, E.D., E.K. Jackson, M.B. Turner, R. Virmani and M.B. Forman, 1991. Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow, Am. Heart J. 122, 1283.
34. 2-receptor agonists on myocardial reperfusion injury, Am. Heart J. 123, 332.
35. Pitarys, C.J., R. Virmani, H.D. Vildibill, E.K. Jackson and M.B. Forman, 1991, Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period, Circulation 83, 237.
36. Randhawa, M.P.S., R.D. Lasley and R.M. Mentzer, 1995, Salutary effects of exogenous adenosine administration on in vivo myocardial stunning, J. Thorac. Cardiovasc. Surg. 110, 63.
37. Romson, J.L., B.G. Hook, S.L. Kunkel, G.D. Abrams, M.A. Schort and B.R. Lucchesi, 1983, Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog, Circulation 67, 1016.
38. Sekili, S., M.O. Jeroudi, X.L. Tang, M. Zughaib, J.Z. Sun and R. Bolli, 1995, Effect of adenosine on myocardial stunning in the dog, Circ. Res. 76, 82.
39. Silva, P.H., D. Dillon and D.G.L. Van Wylen, 1995, Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction, Cardiovasc. Res. 29, 616.
40. Smolenski, R.T., Z. Kochan, R. McDougall, C. Page, A.M.L. Seymour and M.H. Yacoub, 1994, Endothelial nucleotide catabolism and adenosine production, Cardiovasc. Res. 28, 100.
41. Todd, J.C., M.W. Williams, Z.-O. Zhao, H. Sato, J.E. Jordan and J. Vinten-Johansen, 1995, Polyadenylic acid reduces infarct size via intravascular adenosine receptor mechanisms during reperfusion, FASEB J. 9, A-421.
42. Toombs, C.F., D.S. McGee, W.E. Johnston and J. Vinten-Johansen, 1992, Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia, Circulation 86, 986.
43. 1 selective agonist 2-chloro-N6-cyclopentyl-adenosine (CCPA) causes a sustained limitation of infarct size in rabbits, Cardiovasc. Res. 27, 652.
44. Tsuchida, A., S. Yang, B. Burckhartt, K.M. Mullane, M.V. Cohen and J.M. Downey, 1994, Acadesine extends the window of protection afforded by ischaemic preconditioning, Cardiovasc. Res. 28, 379.
45. Van Belle, H. and P.A.J. Janssen, 1991, Comparative pharmacology of nucleoside transport inhibitors, Nucleosides Nucleotides 10, 975.
46. Van Belle, H., W. Verheten, K. Ver Donck, P.A.J. Janssen and J.I.S. Robertson, 1992, Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor, J. Cardiovasc. Pharmacol. 20, 173.
47. Van Wylen, D.G.L., 1994, Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia, Circulation 89, 2283.
48. Van Wylen, D.G.L., J. Willis, J. Sodhi, R.J. Weiss, R.D. Lasley and R.M. Mentzer Jr., 1990, Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow, Am. J. Physiol. 258, H1642.
49. ATP channels, Circulation 89, 1229.
50. Young, M.A. and K. Mullane, 1991, Progressive cardiac dysfunction with repeated pacing-induced ischemia: pretection by AICA-riboside, Am. J. Physiol. 261, H1570.
51. 1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia, Cardiovasc. Res. 28, 270.
52. Zhao, Z.Q., M.W. Williams, H. Sato, D.A. Hudspeth, D.S. McGee, J. Vinten-Johansen and D.G.L. Van Wylen, 1995, Acadesine reduces myocardial infarct size by an adenosine mediated mechanism, Cardiovasc. Res. 29, 495.
53. Zughaib, M.E., A.S. Abd-Elfattah, M.O. Jeroudi, J.Z. Sun, S. Sekili, X.L. Tang and R. Bolli, 1993, Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects, Circulation 88, 2359.